fig10
![Isocucurbitacin B inhibits glioma growth through PI3K/AKT pathways and increases glioma sensitivity to TMZ by inhibiting hsa-mir-1286a](https://image.oaes.cc/f7feab68-5c6b-49da-a16d-a6f35b649abb/cdr7001.fig.10.jpg)
Figure 10. IsocuB inhibits tumor growth in nude mice. (A) Bossing of the mass in nude mice: the control group is shown above, and the treatment group is shown below; (B) Bossing: control group at the top and treatment group at the bottom; (C) Body weight changes in nude mice; (D) Daily tumor volume changes after administration (**P < 0.01, ****P < 0.0001 vs. control group); (E) The bossing weight (****P < 0.0001 vs. control group); (F) Bossing weight/body weight (****P < 0.0001 vs. control group). IsocuB: Isocucurbitacin B.